|
|
||||||||
1 Exercise Biochemistry Laboratory, Department of Kinesiology, California State University Northridge, Northridge 91330-8287; and Departments of 2 Neuroscience and 3 Pharmacology, Amgen Incorporated, Thousand Oaks, California 91320-1799
In addition to
suppressing appetite, leptin may also modulate insulin secretion and
action. Leptin was administered here to insulin-resistant rats to
determine its effects on secretagogue-stimulated insulin release, whole
body glucose disposal, and insulin-stimulated skeletal muscle glucose
uptake and transport. Male Wistar rats were fed either a normal (Con)
or a high-fat (HF) diet for 3 or 6 mo. HF rats were then treated with
either vehicle (HF), leptin (HF-Lep, 10 mg · kg
1 · day
1 sc), or
food restriction (HF-FR) for 12-15 days. Glucose tolerance and
skeletal muscle glucose uptake and transport were significantly impaired in HF compared with Con. Whole body glucose tolerance and
rates of insulin-stimulated skeletal muscle glucose uptake and
transport in HF-Lep were similar to those of Con and greater than those
of HF and HF-FR. The insulin secretory response to either glucose or
tolbutamide (a pancreatic
-cell secretagogue) was not significantly
diminished in HF-Lep. Total and plasma membrane skeletal muscle GLUT-4
protein concentrations were similar in Con and HF-Lep and greater than
those in HF and HF-FR. The findings suggest that chronic leptin
administration reversed a high-fat diet-induced insulin-resistant
state, without compromising insulin secretion.
ob gene product; high-fat diet; glucose tolerance; glucose uptake and transport; GLUT-4 protein
This article has been cited by other articles:
![]() |
B. B. Yaspelkis III, S. J. Lessard, D. W. Reeder, J. J. Limon, M. Saito, D. A. Rivas, I. Kvasha, and J. A. Hawley Exercise reverses high-fat diet-induced impairments on compartmentalization and activation of components of the insulin-signaling cascade in skeletal muscle Am J Physiol Endocrinol Metab, October 1, 2007; 293(4): E941 - E949. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Dube, B. A. Bhatt, N. Dedousis, A. Bonen, and R. M. O'Doherty Leptin, skeletal muscle lipids, and lipid-induced insulin resistance Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2007; 293(2): R642 - R650. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. J. Herr, J. R. Bernard, D. W. Reeder, D. A. Rivas, J. J. Limon, and B. B. Yaspelkis III Insulin-stimulated plasma membrane association and activation of Akt2, aPKC {zeta} and aPKC {lambda} in high fat fed rodent skeletal muscle J. Physiol., June 1, 2005; 565(2): 627 - 636. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. D. Krisan, D. E. Collins, A. M. Crain, C. C. Kwong, M. K. Singh, J. R. Bernard, and B. B. Yaspelkis III Resistance training enhances components of the insulin signaling cascade in normal and high-fat-fed rodent skeletal muscle J Appl Physiol, May 1, 2004; 96(5): 1691 - 1700. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. R. Steinberg, M. L. Parolin, G. J. F. Heigenhauser, and D. J. Dyck Leptin increases FA oxidation in lean but not obese human skeletal muscle: evidence of peripheral leptin resistance Am J Physiol Endocrinol Metab, July 1, 2002; 283(1): E187 - E192. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. R. Steinberg, D. J. Dyck, J. Calles-Escandon, N. N. Tandon, J. J. F. P. Luiken, J. F. C. Glatz, and A. Bonen Chronic Leptin Administration Decreases Fatty Acid Uptake and Fatty Acid Transporters in Rat Skeletal Muscle J. Biol. Chem., March 8, 2002; 277(11): 8854 - 8860. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. R. Steinberg, A. Bonen, and D. J. Dyck Fatty acid oxidation and triacylglycerol hydrolysis are enhanced after chronic leptin treatment in rats Am J Physiol Endocrinol Metab, March 1, 2002; 282(3): E593 - E600. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |